Characterization of Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

ConditionCancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University

About this trial

The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies. The main question it aims to answer is:

Does cosmeceutical topical moisturizers help with skin dryness?

Participants will:

* Visit the clinic for a baseline visit to complete skin evaluation and tests. * Apply cosmeceutical topical moisturizers daily from baseline up until the follow-up visit. * Visit the clinic for a follow-up visit (approximately 2-4 weeks from baseline) for a repeat skin evaluation and tests.

Eligibility criteria

Qualifiers

Adult patient (18 years or older).

Patients diagnosed with cancer.

Patient receiving cancer treatment or therapy (receiving chemotherapy, targeted treatment, hormonal therapy, and/or immune checkpoint inhibitors).

Patient experiencing a dermatological adverse event from a cancer treatment or therapy.

Disqualifiers

Patient is unable to understand scope of the study.

Patient is unable to provide written informed consent.

Patient is healthy.

Trial design

Treatments tested in this trial

  • La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash
  • La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream
  • La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+)

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators